A vaccine? Travel stocks to lift on successful drug trial

A vaccine? Travel stocks to lift on successful drug trial
Rebecca Howard
Successful data from a late-stage covid-19 vaccine trial will give beleaguered travel stocks including Air New Zealand and Auckland International Airport a lift, as well as companies with direct exposure to foreign visitors like SkyCity Entertainment Group.Wall Street — already pushing higher on Joe Biden’s win — jumped when US drugmaker Pfizer and its German partner BioNTech said data from the large-scale trial of their vaccine showed it was more than 90 percent effective in preventing covid-19.“We are reaching this cri...

More Markets

NZ sharemarket claws back to end the week up 0.5%
Markets Market close

NZ sharemarket claws back to end the week up 0.5%

Index rumours drive prices on two shares. 

Graham Skellern 13 Dec 2024
Staff leave Meridian after retail 'reset'
Markets

Staff leave Meridian after retail 'reset'

Expect a very different approach from Meridian in 2025, executive says.

John Anthony 13 Dec 2024
NZX, NZSA want level playing field in climate reporting
Markets

NZX, NZSA want level playing field in climate reporting

Climate reporting liabilities for company directors could soon be eased.

Greg Hurrell 13 Dec 2024
Cannasouth delisting keeps Petterson in charge
Markets

Cannasouth delisting keeps Petterson in charge

Cannasouth major shareholders pushed to end voluntary administration they had called in.

Garth Bray 13 Dec 2024